Web Stats Provided By Google Analytics

Tuesday, April 30, 2013

FDA Tells Delcath No Approval Without New Clinical Trial

In a scorching review, the FDA makes it fairly clear that Melblez will not be approved until Delcath conducts a new clinical trial.

http://www.thestreet.com/story/11909450/1/fda-tells-delcath-no-approval-without-new-clinical-trial.html?cm_ven=RSSFeed&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+tsc%2Ffeeds%2Frss%2Flatest-stories+%28TheStreet.com+Latest+Headlines%29

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts